Procardia XL (nifedipine) NDC 0069-2660

NDC codes

FDA NDC Directory

Product NDC (as listed)0069-2660Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00069-2660Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0069-2660-41	00069266041	100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (0069-2660-41)Marketed from Sep 6, 1989
0069-2660-66	00069266066	100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0069-2660-66)Marketed from Sep 6, 1989

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Procardia XLSuffix: XL
Generic name (nonproprietary): nifedipine
Active ingredients: Nifedipine — 60 mg/1
Dosage form: Tablet, Film coated, Extended release
Route: Oral
Labeler: Pfizer Laboratories Div Pfizer Inc
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 019684
Marketing start: Sep 6, 1989
Listing expires: Dec 31, 2026
Other FDA classes: Calcium Channel Antagonists (Mechanism)Dihydropyridines (Chemical structure)
Identifiers: Product ID 0069-2660_c24a0478-46d4-413a-8d48-c21af0bc10e4SPL ID c24a0478-46d4-413a-8d48-c21af0bc10e4SPL set ID 8ebcb33c-f43b-4b36-9f94-9774b2a59e06RxCUI 207772, 207773, 207774, 1812011, 1812013, 1812015UNII I9ZF7L6G2L
Pharmacologic class: Dihydropyridine Calcium Channel Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400069266041 followed by a unit qualifier and the quantity

Package 00069-2660-41. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 16, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE I. Vasospastic Angina PROCARDIA XL is indicated for the management of vasospastic angina confirmed by any of the following criteria: 1) classical pattern of angina at rest accompanied by ST segment elevation, 2) angina or coronary artery spasm provoked by ergonovine, or 3) angiographically demonstrated coronary artery spasm. In those patients who have had angiography, the presence of significant fixed obstructive disease is not incompatible with the diagnosis of vasospastic angina, provided that the above criteria are satisfied. PROCARDIA XL may also be used where the clinical presentation suggests a possible vasospastic component, but where vasospasm has not been confi…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 019684

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 019684
Product	Strength	Form · route	Labeler	Product NDC
Procardia XLnifedipine	Nifedipine 30 mg/1	Tablet, Film coated, Extended releaseOral	Pfizer Laboratories Div Pfizer Inc	0069-2650